-
1
-
-
0021162666
-
Leukemic cell differentiation in childhood leukemia. Analysis by enzyme markers
-
Gaedick G, Drexler HG. Leukemic cell differentiation in childhood leukemia. Analysis by enzyme markers. Eur J Pediatr 1984;142:157-164.
-
(1984)
Eur J Pediatr
, vol.142
, pp. 157-164
-
-
Gaedick, G.1
Drexler, H.G.2
-
3
-
-
0019811994
-
Purine pathway enzyme abnormalities in acute lymphoblastic leukemia
-
Poplak DG, Blatt J, Reaman G. Purine pathway enzyme abnormalities in acute lymphoblastic leukemia. Cancer Res. 1981;41:4824-4832.
-
(1981)
Cancer Res
, vol.41
, pp. 4824-4832
-
-
Poplak, D.G.1
Blatt, J.2
Reaman, G.3
-
4
-
-
0017084726
-
Human adenosine deaminase distribution and properties
-
Van der Weyden MB, Kelly WN. Human adenosine deaminase distribution and properties. J Biol Chem. 1976;251:4448-5453.
-
(1976)
J Biol Chem
, vol.251
, pp. 4448-5453
-
-
Van Der Weyden, M.B.1
Kelly, W.N.2
-
5
-
-
0020507785
-
Enzyme analysis of lymphoproliferative diseases: A useful addition to cell surface phenotyping
-
Van de Griend RJ, Van de Reijden HJ, Bolhuis RLH, Melief CJM, Von de Borne AEG, Roos D. Enzyme analysis of lymphoproliferative diseases: a useful addition to cell surface phenotyping. Blood. 1983;62:669-676.
-
(1983)
Blood
, vol.62
, pp. 669-676
-
-
Van De Griend, R.J.1
Van De Reijden, H.J.2
Bolhuis, R.L.H.3
Melief, C.J.M.4
Von De Borne, A.E.G.5
Roos, D.6
-
6
-
-
0019512909
-
The biochemical and clinical consequences of 2′-deoxycoformicin in refractory lymphoproliferative malignancy
-
Grever MR, Siaw MFE, Jacob WF, Neidhart JA, Miser JS, Coleman MS, Hutton JJ, Balcerzak SP. The biochemical and clinical consequences of 2′-deoxycoformicin in refractory lymphoproliferative malignancy. Blood. 1981;57:406-417.
-
(1981)
Blood
, vol.57
, pp. 406-417
-
-
Grever, M.R.1
Siaw, M.F.E.2
Jacob, W.F.3
Neidhart, J.A.4
Miser, J.S.5
Coleman, M.S.6
Hutton, J.J.7
Balcerzak, S.P.8
-
8
-
-
0017263711
-
Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies
-
Meier J, Coleman MS, Hutton JJ. Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies. Br J Cancer. 1976;33:312-319.
-
(1976)
Br J Cancer
, vol.33
, pp. 312-319
-
-
Meier, J.1
Coleman, M.S.2
Hutton, J.J.3
-
9
-
-
0017703533
-
Adenosine deaminase activity in lymphocytes of normal persons, leukemic patients and kidney-transplant recipients
-
Yasmineh WG, Brynes RK, Lum CT, Abbasnezhat M. Adenosine deaminase activity in lymphocytes of normal persons, leukemic patients and kidney-transplant recipients. Clin Chem. 1977; 23:2024-2029.
-
(1977)
Clin Chem
, vol.23
, pp. 2024-2029
-
-
Yasmineh, W.G.1
Brynes, R.K.2
Lum, C.T.3
Abbasnezhat, M.4
-
10
-
-
0001059875
-
Serum adenosine deaminase: Methodology and clinical applications
-
Koehler LH, Benz EJ. Serum adenosine deaminase: methodology and clinical applications. Clin Chem. 1962;8:133-142.
-
(1962)
Clin Chem
, vol.8
, pp. 133-142
-
-
Koehler, L.H.1
Benz, E.J.2
-
11
-
-
0015540570
-
Identification of the ezymatic pathways of nucleotide metabolism in human lymphocytes and leukemic cells
-
Scholar EM, Calabresi P. Identification of the ezymatic pathways of nucleotide metabolism in human lymphocytes and leukemic cells. Cancer Res 1973;33:94-101.
-
(1973)
Cancer Res
, vol.33
, pp. 94-101
-
-
Scholar, E.M.1
Calabresi, P.2
-
13
-
-
0015338306
-
Leukocyte adenosine deaminase. Phenotypes in acute leukemia
-
Bloom GE. Leukocyte adenosine deaminase. Phenotypes in acute leukemia. Cancer. 1972;29: 1327-1333.
-
(1972)
Cancer
, vol.29
, pp. 1327-1333
-
-
Bloom, G.E.1
-
15
-
-
0000900192
-
-
Bergmeyer HU, ed. New York: Academic Press
-
Giusti G. In: Bergmeyer HU, ed. Methods of Enzymatic Analysts, 2d ed, Vol 2. New York: Academic Press; 1974:1092-1099.
-
(1974)
Methods of Enzymatic Analysts, 2d Ed
, vol.2
, pp. 1092-1099
-
-
Giusti, G.1
-
16
-
-
85069078995
-
Remission induction with adenosine deaminase inhibitor 2′-deoxycoformycin in T lymphoblastic leukemia
-
Prentice HG, Smith JF, Ganeshaguru K, Wonke B, Bradstock KF, Janossy J, Goldstone AH, Hoffbrand AV. Remission induction with adenosine deaminase inhibitor 2′-deoxycoformycin in T lymphoblastic leukemia. Lancet 1980;2:170-176
-
(1980)
Lancet
, vol.2
, pp. 170-176
-
-
Prentice, H.G.1
Smith, J.F.2
Ganeshaguru, K.3
Wonke, B.4
Bradstock, K.F.5
Janossy, J.6
Goldstone, A.H.7
Hoffbrand, A.V.8
|